错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The correlation of CT-derived muscle density, skeletal muscle index, and visceral adipose tissue with nutritional status in severely injured patients

  • Elaine P. X. van Ee,
  • Esmee A. H. Verheul,
  • Suzan Dijkink,
  • Pieta Krijnen,
  • Wouter Veldhuis,
  • Shirin S. Feshtali,
  • Laura Avery,
  • Claudia J. Lucassen,
  • Sven D. Mieog,
  • John O. Hwabejire,
  • Inger B. Schipper

摘要

Background

This study explored if computerized tomography-derived body composition parameters (CT-BCPs) are related to malnutrition in severely injured patients admitted to the Intensive Care Unit (ICU).

Methods

This prospective cohort study included severely injured (Injury Severity Score ≥ 16) patients, admitted to the ICU of three level-1 trauma centers between 2018 and 2022. Abdominal CT scans were retrospectively analyzed to assess the CT-BCPs: muscle density (MD), skeletal muscle index (SMI), and visceral adipose tissue (VAT). The Subjective Global Assessment was used to diagnose malnutrition at ICU admission and on day 5 of admission, and the modified Nutrition Risk in Critically ill at admission was used to assess the nutritional risk.

Results

Seven (11%) of the 65 analyzed patients had malnutrition at ICU admission, increasing to 23 patients (35%) on day 5. Thirteen (20%) patients had high nutritional risk. CT-BCPs were not related to malnutrition at ICU admission and on day 5. Patients with high nutritional risk at admission had lower MD (median (IQR) 32.1 HU (25.8–43.3) vs. 46.9 HU (37.7–53.3); p < 0.01) and higher VAT (median 166.5 cm2 (80.6–342.6) vs. 92.0 cm2 (40.6–148.2); p = 0.01) than patients with low nutritional risk.

Conclusion

CT-BCPs do not seem related to malnutrition, but low MD and high VAT may be associated with high nutritional risk. These findings may prove beneficial for clinical practice, as they suggest that CT-derived parameters may provide valuable information on nutritional risk in severely injured patients, in addition to conventional nutritional assessment and screening tools.

Level of Evidence

Level III, Prognostic/Epidemiological.